These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 8971157

  • 1. Molecular analysis of the FHIT gene at 3p14.2 in lung cancer cell lines.
    Yanagisawa K, Kondo M, Osada H, Uchida K, Takagi K, Masuda A, Takahashi T, Takahashi T.
    Cancer Res; 1996 Dec 15; 56(24):5579-82. PubMed ID: 8971157
    [Abstract] [Full Text] [Related]

  • 2. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations.
    Fong KM, Biesterveld EJ, Virmani A, Wistuba I, Sekido Y, Bader SA, Ahmadian M, Ong ST, Rassool FV, Zimmerman PV, Giaccone G, Gazdar AF, Minna JD.
    Cancer Res; 1997 Jun 01; 57(11):2256-67. PubMed ID: 9187130
    [Abstract] [Full Text] [Related]

  • 3. Chromosome 3p14 alterations in lung cancer: evidence that FHIT exon deletion is a target of tobacco carcinogens and asbestos.
    Nelson HH, Wiencke JK, Gunn L, Wain JC, Christiani DC, Kelsey KT.
    Cancer Res; 1998 May 01; 58(9):1804-7. PubMed ID: 9581816
    [Abstract] [Full Text] [Related]

  • 4. Absence of Fhit protein in primary lung tumors and cell lines with FHIT gene abnormalities.
    Sozzi G, Tornielli S, Tagliabue E, Sard L, Pezzella F, Pastorino U, Minoletti F, Pilotti S, Ratcliffe C, Veronese ML, Goldstraw P, Huebner K, Croce CM, Pierotti MA.
    Cancer Res; 1997 Dec 01; 57(23):5207-12. PubMed ID: 9393735
    [Abstract] [Full Text] [Related]

  • 5. Loss of FHIT expression in cervical carcinoma cell lines and primary tumors.
    Greenspan DL, Connolly DC, Wu R, Lei RY, Vogelstein JT, Kim YT, Mok JE, Muñoz N, Bosch FX, Shah K, Cho KR.
    Cancer Res; 1997 Nov 01; 57(21):4692-8. PubMed ID: 9354423
    [Abstract] [Full Text] [Related]

  • 6. Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands.
    Ahmadian M, Wistuba II, Fong KM, Behrens C, Kodagoda DR, Saboorian MH, Shay J, Tomlinson GE, Blum J, Minna JD, Gazdar AF.
    Cancer Res; 1997 Sep 01; 57(17):3664-8. PubMed ID: 9288768
    [Abstract] [Full Text] [Related]

  • 7. The FHIT gene at 3p14.2 is abnormal in breast carcinomas.
    Negrini M, Monaco C, Vorechovsky I, Ohta M, Druck T, Baffa R, Huebner K, Croce CM.
    Cancer Res; 1996 Jul 15; 56(14):3173-9. PubMed ID: 8764101
    [Abstract] [Full Text] [Related]

  • 8. Frequent abnormalities of the putative tumor suppressor gene FHIT at 3p14.2 in pancreatic carcinoma cell lines.
    Simon B, Bartsch D, Barth P, Prasnikar N, Münch K, Blum A, Arnold R, Göke B.
    Cancer Res; 1998 Apr 15; 58(8):1583-7. PubMed ID: 9563464
    [Abstract] [Full Text] [Related]

  • 9. Allelic deletion analysis of the FHIT gene predicts poor survival in non-small cell lung cancer.
    Burke L, Khan MA, Freedman AN, Gemma A, Rusin M, Guinee DG, Bennett WP, Caporaso NE, Fleming MV, Travis WD, Colby TV, Trastek V, Pairolero PC, Tazelaar HD, Midthun DE, Liotta LA, Harris CC.
    Cancer Res; 1998 Jun 15; 58(12):2533-6. PubMed ID: 9635574
    [Abstract] [Full Text] [Related]

  • 10. Loss of FHIT function in lung cancer and preinvasive bronchial lesions.
    Sozzi G, Pastorino U, Moiraghi L, Tagliabue E, Pezzella F, Ghirelli C, Tornielli S, Sard L, Huebner K, Pierotti MA, Croce CM, Pilotti S.
    Cancer Res; 1998 Nov 15; 58(22):5032-7. PubMed ID: 9823304
    [Abstract] [Full Text] [Related]

  • 11. Identification of unstable sequences within the common fragile site at 3p14.2: implications for the mechanism of deletions within fragile histidine triad gene/common fragile site at 3p14.2 in tumors.
    Corbin S, Neilly ME, Espinosa R, Davis EM, McKeithan TW, Le Beau MM.
    Cancer Res; 2002 Jun 15; 62(12):3477-84. PubMed ID: 12067991
    [Abstract] [Full Text] [Related]

  • 12. FHIT gene alterations in esophageal cancer and ulcerative colitis (UC).
    Zou TT, Lei J, Shi YQ, Yin J, Wang S, Souza RF, Kong D, Shimada Y, Smolinski KN, Greenwald BD, Abraham JM, Harpaz N, Meltzer SJ.
    Oncogene; 1997 Jul 03; 15(1):101-5. PubMed ID: 9233782
    [Abstract] [Full Text] [Related]

  • 13. Loss of Fhit is frequent in stage I non-small cell lung cancer and in the lungs of chronic smokers.
    Tseng JE, Kemp BL, Khuri FR, Kurie JM, Lee JS, Zhou X, Liu D, Hong WK, Mao L.
    Cancer Res; 1999 Oct 01; 59(19):4798-803. PubMed ID: 10519387
    [Abstract] [Full Text] [Related]

  • 14. Structure and expression of the human FHIT gene in normal and tumor cells.
    Druck T, Hadaczek P, Fu TB, Ohta M, Siprashvili Z, Baffa R, Negrini M, Kastury K, Veronese ML, Rosen D, Rothstein J, McCue P, Cotticelli MG, Inoue H, Croce CM, Huebner K.
    Cancer Res; 1997 Feb 01; 57(3):504-12. PubMed ID: 9012482
    [Abstract] [Full Text] [Related]

  • 15. Molecular analysis of the FHIT gene in human prostate cancer.
    Latil A, Bièche I, Fournier G, Cussenot O, Pesche S, Lidereau R.
    Oncogene; 1998 Apr 09; 16(14):1863-8. PubMed ID: 9583683
    [Abstract] [Full Text] [Related]

  • 16. Frequent abnormalities of FHIT, a candidate tumor suppressor gene, in head and neck cancer cell lines.
    Mao L, Fan YH, Lotan R, Hong WK.
    Cancer Res; 1996 Nov 15; 56(22):5128-31. PubMed ID: 8912845
    [Abstract] [Full Text] [Related]

  • 17. Alterations of the FHIT gene in human hepatocellular carcinoma.
    Yuan BZ, Keck-Waggoner C, Zimonjic DB, Thorgeirsson SS, Popescu NC.
    Cancer Res; 2000 Feb 15; 60(4):1049-53. PubMed ID: 10706123
    [Abstract] [Full Text] [Related]

  • 18. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation.
    Wali A, Srinivasan R, Shabnam MS, Majumdar S, Joshi K, Behera D.
    Mol Cancer Res; 2006 Feb 15; 4(2):93-9. PubMed ID: 16513840
    [Abstract] [Full Text] [Related]

  • 19. Analysis of the fragile histidine triad gene in primary gastric carcinomas and gastric carcinoma cell lines.
    Tamura G, Sakata K, Nishizuka S, Maesawa C, Suzuki Y, Iwaya T, Terashima M, Saito K, Satodate R.
    Genes Chromosomes Cancer; 1997 Sep 15; 20(1):98-102. PubMed ID: 9290961
    [Abstract] [Full Text] [Related]

  • 20. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
    Wang YC, Chen CY, Chen SK, Cherng SH, Ho WL, Lee H.
    Cancer Res; 1998 Jan 15; 58(2):328-33. PubMed ID: 9443413
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.